Active Surveillance for Complete Responders in Oesophageal SCC: Better Progression-Free Survival

Patients with oesophageal squamous cell carcinoma who underwent active surveillance after chemoradiotherapy showed comparable overall survival but better progression-free survival than those who had planned surgery. The two groups had similar overall recurrence rates, with locoregional recurrence more common in the active surveillance group and systemic recurrence more common in the surgery group. Active surveillance was found to be feasible and safe for patients with complete response after chemoradiotherapy.